Aurobindo Pharma Ltd. (AUROPHARMA): Aurobindo Pharma Share Price rises 2.32% as stock gains today

Published: 17 September 2026 at 12:19:07 PM IST

Aurobindo Pharma Share Price moved higher today, with the stock at Rs 1,679.10, up 2.32% from the previous close of Rs 1,641.00. The company’s market capitalisation stands at Rs 95,794.67 crore, placing the move in a large-value context for Aurobindo Pharma Ltd. The opening trade was Rs 1,626.75, the day’s low was also Rs 1,626.75, and the session high reached Rs 1,681.80. On turnover, the stock recorded Rs 0.50 crore. The supplied data confirms a same-day price rise, but it does not establish a company-specific catalyst. For readers tracking Aurobindo Pharma Share Price Today, the move matters because it combines a positive close, a narrow intraday range and a high market capitalisation in a healthcare name that remains active in Stock Market Today discussions on Univest.

In the latest Aurobindo Pharma Stock News, the share price rise also brings the company back into focus for investors comparing pharma names across NSE and BSE. Univest’s market data shows that this was a verified price event rather than a narrative-led call. The question for follow-up research is not only why Aurobindo Pharma is rising today, but how today’s price action fits alongside its fundamentals, valuation and healthcare-sector benchmark on Univest.

Aurobindo Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,679.1
Previous Close	Rs 1,641
Today's Move	Rs 38.1 (+2.32%)
Open	Rs 1,626.75
High	Rs 1,681.8
Low	Rs 1,626.75
Turnover	Rs 0.5 crore
Market Capitalisation	Rs 95,794.67 crore
Market Cap Category	Large Cap

Aurobindo Pharma Ltd. (AUROPHARMA) rose to Rs 1,679.1 from the previous close of Rs 1,641, a move of Rs 38.1 or 2.32%. The stock opened at Rs 1,626.75, reached a high of Rs 1,681.8, recorded a low of Rs 1,626.75.

Aurobindo Pharma Share Price today rose Rs 38.10, or 2.32%, to Rs 1,679.10. The stock opened at Rs 1,626.75, stayed above that level through the session, and touched a high of Rs 1,681.80 before settling near the upper end of the day’s range. The previous close was Rs 1,641.00, so the day’s move was a clear share price gain in confirmed market data. Turnover was Rs 0.50 crore, which is a factual traded-value metric and should be read only as part of the day’s price record. On Univest, this makes Aurobindo Pharma Share Price an active stock-news item for investors scanning Stocks in News, Top Gainers Today and Share Market Today themes without assuming any unverified cause.

Aurobindo Pharma Ltd. (AUROPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 95,794.67 crore
P/E Ratio	25.43x
P/B Ratio	2.43x
ROE	9.93%
ROCE	12.76%
EPS	Rs 64.52
Book Value Per Share	Rs 676.49
Dividend Yield	0.24%

Aurobindo Pharma Ltd. (AUROPHARMA) fundamental metrics show P/E 25.43x, P/B 2.43x, ROE 9.93%, ROCE 12.76%. These figures provide context only and are not a buy or sell signal.

Aurobindo Pharma Ltd. has a market capitalisation of Rs 95794.67 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.43x, P/B at 2.43x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.93% and ROCE of 12.76%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 64.52, book value per share of Rs 676.49, dividend yield of 0.24%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	25.43x
Benchmark Median P/E	31.35x
Benchmark Average P/E	47.81x
Benchmark P/E Range	3.45x to 661.74x
Company P/B Ratio	2.43x
Benchmark Median P/B	2.98x
Company ROE	9.93%
Benchmark Median ROE	11.78%
Company ROCE	12.76%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 95,794.67 crore
Benchmark Median Market Cap	Rs 735.67 crore

Aurobindo Pharma Ltd. (AUROPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 25.43x, which is below the benchmark median of 31.35x, a difference of -18.88%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Aurobindo Pharma Ltd. (AUROPHARMA) has a ROE of 9.93%, which is below the benchmark median of 11.78%, a difference of -15.7%. Aurobindo Pharma Ltd. (AUROPHARMA) has a ROCE of 12.76%, which is below the benchmark median of 13.65%, a difference of -6.52%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,40,277.97	36.77	5.14	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,43,965.63	83.5	13.83	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.11	20.44	26.76	19.27
Cipla Ltd.	CIPLA	1,09,949.53	32.59	3.12	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,09,625.67	24.42	4.09	19.69	21.39

Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 25.43x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.93% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 12.76% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Aurobindo Pharma Ltd. (AUROPHARMA) has a market capitalisation of Rs 95,794.67 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Aurobindo Pharma

• Aurobindo Pharma Share Price rose 2.32% today to Rs 1,679.10 after closing at Rs 1,641.00 in the previous session.
• The stock moved between Rs 1,626.75 and Rs 1,681.80 during the day, showing a defined intraday range.
• Market capitalisation stands at Rs 95,794.67 crore, which gives the move a large-company context.
• The P/E ratio of 25.43 and P/B ratio of 2.43 provide a valuation snapshot for Aurobindo Pharma Share Price analysis.
• ROE of 9.93%, ROCE of 12.76%, EPS of Rs 64.52 and book value of Rs 676.49 provide fundamental context for Aurobindo Pharma Stock News.

About Aurobindo Pharma

Aurobindo Pharma Ltd. is a healthcare company operating in the Pharmaceuticals & Drugs industry. Its business belongs to the Indian pharmaceutical ecosystem, where listed companies are often assessed through earnings, valuation and sector benchmarks rather than a single day’s price movement. For Aurobindo Pharma Share Price readers, the company’s key identity is tied to its role in pharmaceuticals, not to any short-term market event.

The company’s market position is reflected in its Rs 95,794.67 crore market capitalisation, while its financial profile is captured by the supplied P/E, P/B, ROE, ROCE, EPS, book value and dividend yield. That combination helps explain why Aurobindo Pharma Share Price Today attracts attention on Univest when the stock moves. The company sits within a broad healthcare peer group, so investors often read it alongside sector performance, industry benchmark data and comparable listed pharma names.

Track Aurobindo Pharma Share Price on Univest

Use Aurobindo Pharma Ltd. (AUROPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

For readers who follow Aurobindo Pharma Share News, Univest is designed to keep the company’s share price update, company news and sector context in one connected view. That makes it easier to review Aurobindo Pharma Latest News and the broader stock analysis without switching between scattered sources.

Frequently Asked Questions

Why did Aurobindo Pharma Share Price rise today?

Ans. Aurobindo Pharma Share Price rose 2.32% to Rs 1,679.10 today. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind the move. The previous close was Rs 1,641.

What is Aurobindo Pharma Share Price today?

Ans. Aurobindo Pharma Share Price today is Rs 1,679.10. It moved up Rs 38.10 from the previous close of Rs 1,641.00, with the session high at Rs 1,681.80. The previous close was Rs 1,641.

How much did Aurobindo Pharma Share Price gain today?

Ans. The stock gained Rs 38.10, which equals 2.32% for the day. That makes Aurobindo Pharma one of the stocks in focus among healthcare names in today’s market update. The previous close was Rs 1,641.

What is Aurobindo Pharma’s market capitalisation?

Ans. Aurobindo Pharma’s market capitalisation is Rs 95,794.67 crore. Market cap shows company size, and this figure places the stock well above the industry median in the supplied healthcare benchmark. The company operates in the Healthcare sector.

How does Aurobindo Pharma compare on valuation?

Ans. Aurobindo Pharma trades at a P/E of 25.43 and a P/B of 2.43. Both are below the same-industry median in the supplied snapshot, which gives context to the share price move.

What do Aurobindo Pharma’s profitability ratios show?

Ans. Aurobindo Pharma reports ROE of 9.93% and ROCE of 12.76%. These figures are slightly below the industry medians shown in the sector snapshot, offering a measured profitability backdrop. ROE stands at 9.93%.

How are EPS and book value relevant for Aurobindo Pharma Share Price?

Ans. EPS is Rs 64.52 and book value per share is Rs 676.49. EPS shows earnings attributable to each share, while book value per share reflects accounting net worth behind each share.